No headlines found.
Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering
Globe Newswire (Mon, 3-Mar 4:00 AM ET)
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
Globe Newswire (Tue, 25-Feb 5:08 PM ET)
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.
Basel Medical Group - trades on the NASDAQ stock market under the symbol BMGL.
As of March 10, 2025, BMGL stock price declined to $3.91 with 123,165 million shares trading.
BMGL has a market cap of $72.18 million. This is considered a Micro Cap stock.
BMGL support price is $3.79 and resistance is $4.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BMGL shares will trade within this expected range on the day.